Triple negative breast cancers are a distinct histopathologic subtype of breast cancer (BC) that accounts for approximately 15% of all invasive BCs [1, 2] where <1% of tumors cells stain positive for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) protein expression. This evidence concerns the gene PGR and breast cancer.